1st European Alliance for Personalised Medicine Congress

Personalising Your Health: A Global Imperative!

27 – 30 NOVEMBER 2017 I BELFAST I NORTHERN IRELAND

REGISTER NOWSUBMIT YOUR ABSTRACT

Patient Agenda

Modern-day patients are much better informed than ever before and are demanding to share in co-decision-making about issues affecting their treatments. They are also hugely in favour of being able to share their own private health data (under strict ethical and privacy provisions) for the benefit of fellow patients and future generations.

Education & Training Agenda

Healthcare professionals (HCPs) are falling behind with front-line knowledge as developments in personalised medicine move swiftly. Europe must put programmes in place to bring, and keep, these HCP up to speed, while improving their interaction skills with patients.

CONGRESS COUNTDOWN

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Regulation Agenda

Proponents of personalised medicine believe that much legislation governing aspects of healthcare are out-of-date and not fit for purpose in these fast-changing times. Despite health largely remaining a Member State competence, regulations and directives must be brought to modern levels through a consensus of experts and key actors, including patients.

Research & Development Agenda

EAPM has promoted the state of art in research which will be a focus of this Congress and its stakeholders have engaged often with IMI and the European Commission (Horizon 2020) to discuss incentives for industry, patients and academics in the area of R&D

Welcome

The European Alliance for Personalised Medicine we would like to invite you to participate in our first Personalised Medicine Congress to be held in the capital of Northern Ireland next November.
Read Welcome Letter

In Close Collaboration With Our Partners

EAPM brings together European healthcare experts, patient advocates involved with chronic diseases, industry, researchers, academics and cross-party Members of the European Parliament (among others). Its aim is to improve patient care by accelerating the development, delivery and uptake of personalised medicine and diagnostics, through consensus building.

The Alliance’s stakeholders focus, not just on the delivery of the right treatment for the right patient at the right time, but also on the right preventative measures to ensure reliable and sustainable healthcare.

In response to the need for a wider understanding of the priorities arising from growing discussion on personalised medicine, EAPM was launched in March 2012 to foster a more integrated approach to the topic among lay and professional stakeholders.

Register for EAPM2017

 

Register Now

Abstract Submissions

 

Submit an Abstract